Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating zoledronic acid for asymptomatic/early-stage multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM) [Phase 2]
Phase 2 clinical trial examining the use of THAL-DEX (thalidomide-dexamethasone) in a double peripheral blood stem cell autotransplantation …
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating Velcade, Trisenox, vitamin C, and melphalan in myeloma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: Effects of Exercise in Combination With Epoetin Alfa [NA]
A completed clinical trial evaluating exercise in combination with epoetin alfa in patients with Multiple myeloma has posted results. The sp…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I [Phase 3]
Phase 3 trial evaluating zoledronic acid in patients with Stage I multiple myeloma was terminated, and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1)) [Phase 1]
Phase 1 trial evaluating the safety, dosing, and preliminary activity of the combination therapy vorinostat and bortezomib in adults with mu…
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON) [Phase 2]
A Phase 2 trial evaluating maintenance therapy with pegylated interferon alfa-2b (PegIntron) after autologous peripheral blood stem cell tra…
-
CLINICAL_TRIALS trial_result · 2011-03-22Clinical Trial Update: Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131 [Phase 1]
A Phase 1 trial of radioimmunotherapy using the B-B4 monoclonal antibody labeled with Iodine-131 for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Quality of Life in Patients With Multiple Myeloma
This clinical trial update reports on a completed study examining quality of life in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma [Phase 2]
Phase 2 clinical trial update on using a conditioning regimen of fludarabine and melphalan for patients with chronic lymphocytic leukemia, l…
-
CLINICAL_TRIALS trial_result · 2011-02-15Clinical Trial Update: Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma [Phase 3]
Phase 3 clinical trial evaluating maintenance therapy with thalidomide plus dexamethasone for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma [NA]
This clinical trial evaluated mixed chimera allogeneic transplantation from matched unrelated donors for treating multiple myeloma. The stud…
-
CLINICAL_TRIALS trial_result · 2011-02-09Clinical Trial Update: Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma [Phase 3]
A Phase 3 randomized trial comparing thalidomide with bortezomib in melphalan-refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies [Phase 1, Phase 2]
This update presents safety and pharmacokinetic data from a Phase 1/2 trial of orally administered gallium maltolate in refractory malignanc…
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating a pentostatin-alemtuzumab preparative regimen for allogeneic peripheral blood stem cell transplantation; the study …
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients. [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Velcade (bortezomib) plus melphalan and prednisone in older untreated multiple myeloma patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma [Phase 2]
A Phase 2 randomized study comparing melphalan + prednisone (MP) versus melphalan + prednisone + thalidomide (MPT) in newly diagnosed elderl…
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates [Phase 2]
Phase 2 trial update of denosumab (AMG 162) in patients with advanced cancer and bone metastases who were receiving IV bisphosphonates; resu…
-
CLINICAL_TRIALS trial_result · 2011-01-06Clinical Trial Update: Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab [Phase 2]
Open-label Phase 2 proof-of-concept study of denosumab in relapsed or plateau-phase multiple myeloma; results were posted in January 2011.
-
CLINICAL_TRIALS trial_result · 2010-12-13Clinical Trial Update: Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating melphalan, prednisone, and lenalidomide in newly diagnosed multiple myeloma completed with results posted in 2010…
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma [Phase 2]
Phase 2 trial evaluating anakinra with or without dexamethasone in patients with smoldering or indolent multiple myeloma; results were poste…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 clinical trial results for a cyclophosphamide, bortezomib, and dexamethasone regimen in newly diagnosed multiple myeloma are reporte…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma [Phase 4]
Clinical trial update for a Phase 4 efficacy study comparing PAD and TAD regimens in newly diagnosed multiple myeloma; the status or results…
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients [Phase 2]
Phase 2 trial of plerixafor (AMD3100) in patients with Non-Hodgkin lymphoma and multiple myeloma has completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF [Phase 2]
This Phase 2 trial evaluates using plerixafor (AMD3100) with G-CSF to enhance mobilization of peripheral blood stem cells in patients with m…